|
1
|
Urquhart SA, Chedid VG, Kane SV. Use of Upadacitinib as Salvage Therapy for Ulcerative Colitis in Pregnancy: A Case Report. Inflamm Bowel Dis 2024:izae146. [PMID: 38970379 DOI: 10.1093/ibd/izae146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/27/2024] [Indexed: 07/08/2024]
Abstract
Lay Summary
Upadacitinib, a selective JAK-1 inhibitor, was used as rescue therapy for ulcerative colitis in the setting of pregnancy following use of mesalamine, vedolizumab, infliximab, and corticosteroids. This resulted in an uncomplicated live full birth without need for surgical intervention.
Collapse
Affiliation(s)
- Siri A Urquhart
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
| | - Victor G Chedid
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
| | - Sunanda V Kane
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
| |
Collapse
|
|
2
|
Dubinsky MC, Charles L, Selmaj KW, Comi G, Krakovich A, Rosen M, van der Woude CJ, Mahadevan U. Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn's Disease, and Relapsing Multiple Sclerosis. Inflamm Bowel Dis 2024:izae011. [PMID: 38267826 DOI: 10.1093/ibd/izae011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/27/2023] [Indexed: 01/26/2024]
Abstract
Lay Summary
This study evaluated pregnancy outcomes in patients with ulcerative colitis, Crohn’s disease, or multiple sclerosis and in healthy volunteers treated with ozanimod. There was no increased incidence of fetal abnormalities or adverse pregnancy outcomes with ozanimod exposure during early pregnancy.
Collapse
Affiliation(s)
- Marla C Dubinsky
- Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | | | - Krzysztof W Selmaj
- Center for Neurology, Lodz, Poland
- Department of Neurology, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland
| | - Giancarlo Comi
- Department of Neurorehabilitation Sciences, Vita-Salute San Raffaele University and Casa di Cura Igea, Milan, Italy
| | | | | | - C Janneke van der Woude
- Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Uma Mahadevan
- Gastroenterology Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
| |
Collapse
|